139 related articles for article (PubMed ID: 1394681)
1. Synthesis, structure and antitumor activity of a water-soluble platinum complex, (1R,3R,4R,5R)-(-)-quinato(1R,2R-cyclohexanediamine)platinum (II).
Hata G; Kitano Y; Kaneko T; Kawai H; Mutoh M
Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1604-5. PubMed ID: 1394681
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, structure and antitumor activity of a new water-soluble platinum complex, (1R,2R-cyclohexanediamine-N,N')[2-hydroxy-4-oxo-2-pentenoato(2-)-O2] platinum(II).
Kawai H; Kitano Y; Mutoh M; Hata G
Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):357-61. PubMed ID: 8500201
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of platinum(IV) and platinum(II) complexes containing 1R,2R-cyclohexanediamine as a ligand.
Yamashita T; Hirose J; Noji M; Saito R; Tomida H; Kidani Y
Biol Pharm Bull; 1993 Oct; 16(10):1014-8. PubMed ID: 8287030
[TBL] [Abstract][Full Text] [Related]
4. Syntheses and antitumor activities of 1R,2R-cyclohexanediamine Pt(II) complexes containing dicarboxylates.
Noji M; Suzuki K; Tashiro T; Suzuki M; Harada K; Masuda K; Kidani Y
Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):221-8. PubMed ID: 3594651
[No Abstract] [Full Text] [Related]
5. A new orally active antitumor 1R,2R-cyclohexanediamine-platinum(IV) complex: trans-(n-valerato)chloro(1R,2R-cyclohexanediamine) (oxalato)platinum(IV).
Kizu R; Nakanishi T; Hayakawa K; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Tashiro T; Kidani Y
Cancer Chemother Pharmacol; 1999; 43(2):97-105. PubMed ID: 9923814
[TBL] [Abstract][Full Text] [Related]
6. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
Siddik ZH; al-Baker S; Thai G; Khokhar AR
Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929
[TBL] [Abstract][Full Text] [Related]
7. An orally active antitumor cyclohexanediamine-Pt(IV) complex: trans,cis,cis-bis(n-valerato)(oxalato)(1R,2R-cyclohexane diamine)Pt(IV).
Kizu R; Nakanishi T; Miyazaki M; Tashiro T; Noji M; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Kidani Y
Anticancer Drugs; 1996 May; 7(3):248-56. PubMed ID: 8791997
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
[TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of steroid-containing platinum (II) complexes of 1R,2R-cyclohexanediamine and 2-(aminomethyl)-cyclohexylamine isomers against leukemia L1210.
Kidani Y; Suzuki K; Noji M; Tashiro T
Biomed Pharmacother; 1989; 43(4):261-4. PubMed ID: 2790146
[TBL] [Abstract][Full Text] [Related]
10. Preparation of antitumor oxaliplatin/cisplatin docking dinuclear platinum complex.
Noji M; Kizu R; Takeda Y; Akiyama N; Yoshizaki I; Eriguchi M; Kidani Y
Biomed Pharmacother; 2005 Jun; 59(5):224-9. PubMed ID: 15919175
[TBL] [Abstract][Full Text] [Related]
11. {(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivo.
Abramkin SA; Jungwirth U; Valiahdi SM; Dworak C; Habala L; Meelich K; Berger W; Jakupec MA; Hartinger CG; Nazarov AA; Galanski MS; Keppler BK
J Med Chem; 2010 Oct; 53(20):7356-64. PubMed ID: 20886814
[TBL] [Abstract][Full Text] [Related]
12. Antitumor platinum(II) complexes of N-monoalkyl-1R, 2R-diaminocyclohexane derivatives with alkyl groups as hindrance.
Sun Y; Yin R; Gou S; Zhaojian
J Inorg Biochem; 2012 Jul; 112():68-76. PubMed ID: 22561544
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, cytotoxicity and antitumor activity of platinum(II) complexes of cyclopentanecarboxylic acid hydrazide.
Kushev D; Gorneva G; Taxirov S; Spassovska N; Grancharov K
Biol Chem; 1999 Nov; 380(11):1287-94. PubMed ID: 10614821
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antitumor activity of a series of (aminoethylpyrrolidine) platinum complexes.
Khokhar AR; Brown DB; McCormack JJ; Hacker MP
Cancer Chemother Pharmacol; 1989; 23(1):15-8. PubMed ID: 2909285
[TBL] [Abstract][Full Text] [Related]
15. A new platinum-bromine cyclohexanediamine complex from the family of cancer cytostatics.
Pazout R; Maixner J; Holakovská J; Dušek M; Kačer P
Acta Crystallogr C; 2012 Dec; 68(Pt 12):m340-3. PubMed ID: 23221243
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, and antitumor activity of 1,2-bis(diphenylphosphino) ethane platinum(II) and palladium(II) complexes.
Khokhar AR; Xu QY; Siddik ZH
J Inorg Biochem; 1990 Jun; 39(2):117-23. PubMed ID: 2380705
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of new platinum complexes.
Brown DB; Khokhar AR; Hacker MP; Lokys L; Burchenal JH; Newman RA; McCormack JJ; Frost D
J Med Chem; 1982 Aug; 25(8):952-6. PubMed ID: 7120284
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro antiproliferative activity of platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane as ligands.
Sun Y; Liu F; Gou S; Cheng L; Fang L; Yin R
Eur J Med Chem; 2012 Sep; 55():297-306. PubMed ID: 22867527
[TBL] [Abstract][Full Text] [Related]
19. Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.
Zhou Z; Chen F; Xu G; Gou S
Bioorg Med Chem Lett; 2016 Jan; 26(2):322-327. PubMed ID: 26711148
[TBL] [Abstract][Full Text] [Related]
20. Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
Ali MS; Khan SR; Ojima H; Guzman IY; Whitmire KH; Siddik ZH; Khokhar AR
J Inorg Biochem; 2005 Mar; 99(3):795-804. PubMed ID: 15708801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
